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Deletion of a C-terminal fragment including a putative transmembrane-like region of the a 1,6-FucT from Rhizobium sp. led to a mutant
enzyme retaining the main catalytic and speciﬁcity features of the wild-type enzyme. However, such truncation allowed us to obtain higher
yields of soluble transferase per unit of biomass and with improved stability in solution, which represent a signiﬁcant advantage.
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Abstract—Recently we have over-expressed the enzyme a 1,6-fucosyltransferase from Rhizobium sp. in Escherichia coli. In this
heterologous system the enzyme was mainly expressed as inclusion bodies and the one that was expressed soluble showed a short-
lasting activity in solution due to precipitation of the protein. A structural analysis of the sequence using the TMpred program
predicted a highly hydrophobic region of 19 aa close to the C-terminal of the protein. In order to investigate the inﬂuence of this
region on the formation of inclusion bodies and the precipitation from solution, we cloned a truncated version of the protein where
a C-terminal fragment of 65 aa, including the predicted transmembrane-like region, was removed. The resulting protein was
expressed in a soluble form without formation of inclusion bodies. The truncated protein catalyzed the transfer of a fucopyranosyl
moiety from GDP-b-l-Fucose to chitobiose. Comparison of the acceptor speciﬁcity between the truncated a 1,6-fucosyltransferase
and the wild-type enzyme, showed a similar behavior for both enzymes. Our results indicate that the active center is not located in
the C-terminal extreme of the protein in contrast to the case of the mammalian glycosyltransferases. Also, these results indicate that
the a-6-motif III is not directly involved in the catalytic activity of the enzyme. # 2001 Published by Elsevier Science Ltd.
Introduction
Carbohydrates play a broad range of biological func-
tions, mainly related to cell recognition events.1 Many
of these events occur at the very early stage of disease
development and other signaling processes. Control of
such recognition processes has become an important
target for new drug development. Glycosyltransferases
of the Leloir pathway2 have become powerful tools for
the synthesis of oligosaccharides through their strict
control over the stereo- and regioselectivity of glycosidic
bond formation.3 One major drawback of glycosyl-
transferases in synthesis is their limited commercial
availability. Since bacteria produce glycosyltransferases
with similar activities to those of the Leloir-type, one
alternative to overcome this problem is the cloning and
over-expression of bacterial glycosyltransferases.4
Recently we have over-expressed the enzyme a 1,6-
fucosyltransferase from Rhizobium sp. in E. coli.5 In this
heterologous system the enzyme was mainly expressed
as inclusion bodies. Several attempts to refold the pro-
tein solubilizing the pellet with urea or guanidine, fol-
lowed by a slow elimination of the denaturant agent by
dialysis against buﬀer were unsuccessful. Use of diﬀer-
ent folding aids in the dialysis buﬀer,6 including glyci-
dol, Triton X-100, Tween-20 and polyethylene glycol
(PEG) with the same unfruitful result. Additionally, the
enzyme expressed in soluble form lost the activity after
few days due to precipitation of the protein. In view of
these results, we performed a computational analysis of
the secondary structure of the enzyme. The TMpred
program7 predicted a transmembrane-like region of 19
aa close to the C-terminal of the protein.
In this paper, we report the cloning of a truncated ver-
sion of the protein where a C-terminal fragment of 65
aa, including the predicted hydrophobic region, has
been removed. The inﬂuence of this region on the for-
mation of inclusion bodies and precipitation of the wild-
type enzyme has been investigated. We compared the
kinetic behavior of the truncated a 1,6-fucosyltransfer-
ase (a 1,6-FucT) with the wild-type enzyme as well as
the acceptor speciﬁcity. Some structural features are
also discussed.
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Results
C-terminal truncation of  1,6-fucosyltransferase
We performed a computational prediction of the sec-
ondary structure of the a 1,6-FucT (Fig. 1) in order to
detect some structural characteristics that could be
responsible for the tendency of the enzyme to pre-
cipitate. The TMpred program7 identiﬁes potential
highly hydrophobic segments in proteins suggesting that
they could participate in protein-membrane interac-
tions. This program showed three possible transmem-
brane-like helices in the sequence of a 1,6-FucT from
Rhizobium sp., but only one, between the amino acids
258 and 276, could be considered signiﬁcant. The
‘DAS’-Transmembrane Prediction server8 also pre-
dicted a transmembrane-like segment of 13 aa between
the residues 265 and 277. As the predicted hydrophobic
region was close to the C-terminal, we decided to
remove the fragment comprised from the residue 258 to
the C-terminal amino acid (Fig. 1). This fragment
included an a-helix of 11 aa corresponding to the
transmembrane-like segment and three short segments
of 3, 4 and 6 residues, respectively, with potential b-
sheets structure. On the other hand, the expected iso-
electric point (5.39) is not signiﬁcantly changed with
respect to the non-truncated enzyme (5.32).
The truncation of the nodZ gene from Rhizobium sp.
was performed by PCR. The leftward primer contained
15 bp of the 50 end of the coding DNA strain and the
sequence for the restriction enzyme Eco RI. The right-
ward primer was designed to complement 15 bp from
nucleotide 757–771 of the coding strain; the stop codon
TGA and the recognition sequence for Hind III were
also included (Fig. 2). The PCR ampliﬁcation was quite
speciﬁc, and only one band with the expected length
(771 bp) was observed. The band was puriﬁed and
double digested with the above mentioned restriction
enzymes and ligated with the digested vector pKK223-3.
The main features of the resulting expression vector
(pK1,6FucTDS) are shown in Figure 2. The
pK1,6FucTDS plasmid was transformed in E. coli XL1-
Blue MRF0 strain and plated on LB-ampicillin plates.
The presence of the truncated gene in the transformed
cells was checked by restriction analysis of the puriﬁed
plasmids. Out of 10 colonies selected, nine carried the
desired insert. One positive colony was grown on LB
medium containing 250 mg/mL ampicillin and induced
with 1 mM of isopropyl-b-d-thiogalactopyranoside
(IPTG) when the O.D. at 600 nm raised 0.5. The
expression of the recombinant enzyme was analysed by
sodium dodecyl sulphate-polyacrilamide gel electro-
phoresis (SDS-PAGE) from samples taken 3, 5 and 24 h
after induction.
In all cases, an IPTG induced band, matching the
expected molecular weight (29.5 kD), was only observed
in the soluble fraction and formation of inclusion bodies
was not observed. This soluble fraction showed trans-
ferase activity upon the spectrophotometric assay.9 The
production of mutant enzyme per liter of culture was
about 9 U, almost double the previously reported yield
for the wild-type enzyme.5
The possible loss of activity of the truncated enzyme in
solution was tested and compared with that of the wild-
type enzyme (Fig. 3). The activity of the latter was
completely lost after 5 days at 4 C with a half-life of 2
days, due to enzyme precipitation. The deletion of the
C-terminal fragment resulted in a signiﬁcant increase of
Figure 1. Sequence and predicted secondary structure of the a 1,6-FucT from Rhizobium sp. Gray area represent the deleted fragment in the trun-
cated enzyme. Transmembrane-like region is indicated. Bold letters represent the conserved a-6-motifs. a-Helix. b-Sheets.
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the enzyme stability, since after 5 days the truncated
enzyme retained almost the 100% of the activity and no
protein precipitation was observed.
Kinetic and acceptor speciﬁcity studies
Although the truncated a 1,6-FucT retained the trans-
ferase activity, other catalytic properties, such as the
speciﬁcity for substrate, could be aﬀected by the elim-
ination of the C-terminal peptide. Thus, we evaluated
the inﬂuence of the deletion on the speciﬁcity for donor
and acceptor substrates by analysing the kinetic for
donor (GDP-b-l-fucose) at ﬁxed concentration of chit-
obiose and using diﬀerent mono- and oligosaccharides
as acceptors, respectively.
The kinetic parameters KM and Vmax were obtained
from the plot of [s]/n versus [s] (Table 1). This straight-
line plot [eq (2)] is generated by multiplying both sides
of the double-reciprocal equation [eqn (1)] by [s].
1

¼ 1
Vmax
þ KM
Vmax½s ð1Þ
1

¼ 1
Vmax
½s KM
Vmax
ð2Þ
In this plot, known also as Hanes plot or Woolf plot,
the slope of the straight-line is equal to KM/Vmax and
the abscissa intercept is equal to KM. The [s]/n against
[s] plot has the advantage over the most popular double-
reciprocal plot in that the distribution of the errors is
more homogeneous along the straight-line, giving more
accurate results.10
The truncation of the C-terminal fragment led to diﬀer-
ent kinetic parameters between the mutant and the wild-
type enzymes (Table 1). The truncated a 1,6-FucT
showed a 4.5-fold lower apparent KM, indicating a
higher aﬃnity for the GDP-Fuc. The apparent Vmax
also decreased after truncation from 0.58 to 0.135
mM.min1.mg1 protein. Interestingly, the catalytic eﬃ-
ciency (Vmax/KM) was not aﬀected by the C-terminal
deletion (Table 1).
We have also investigated if the acceptor speciﬁcity was
modiﬁed by the enzyme truncation. In Table 2, the
results obtained with the mutant and the wild-type a
1,6-FucT enzymes are summarized.
Figure 2. Construction of the expression plasmid for the C-terminal truncated a 1,6-FucT. The main characteristics of the vector are shown. The
sequence of the primers used for the PCR were as follows: leftward primer 50-GCCGCGAATTCATGTACAATCGATAT-30; rightward primer 50-
CGCGCAAGCTTTCAATCTGCGCTGTGTAA-30.
Table 1. Apparent kinetic parameters of wild-type and C-terminal
truncated a 1,6-FucT for GDP-Fuc
Enzyme KM (mM) Vmax
(mM min1 mg1 protein)
Vmax/KM
Wild-type 72.12 0.58 0.0080
Mutant 15.79 0.13 0.0085
Parameters were determined in the presence of 100 mM of chitobiose
as acceptor substrate.
Figure 3. Stability of wild-type (*) and truncated (*) a 1,6 FucT in
solution at 4 C. Activity was measured using GDP-Fuc (50 mM) as
donor and chitobiose (100 mM) as acceptor.
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As in the case of the wild-type enzyme, the truncated a
1,6-FucT showed a broad speciﬁcity for the acceptor
substrate although some appreciable diﬀerences can be
outlined. Previously reported data have shown that the
a 1,6-FucT’s from Rhizobium sp.11 and Bradyrhizobium
japonicum12 can fucosylate di-, tri-, tetra-, penta- and
hexa-chitin oligomers, showing the highest rates with
the penta- and hexasaccharides. The truncated enzyme
showed an even higher preference for long chitin oligo-
mers than the wild-type. Thus, while the activity of the
wild-type enzyme increased 26% from chitobiose (1) to
chitotetraose (3), the activity of the mutant raised to
170% (Table 2). A signiﬁcant diﬀerence in Vrel was also
observed in the fucosylation of the monosaccharide
GlcNAc (8), being the truncated enzyme two times
more eﬃcient than the wild-type. However, no diﬀer-
ence was observed for the glycosides of GlcNAc 9–12. A
remarkable result was the observation that the mutant
enzyme accepted the branched trisaccharide 7, which, is
not a substrate for the wild-type fucosyltransferase.
Other monosaccharides, such as Glc (14), ManNAc (15)
and GalNAc(16) were substrates of the mutant with
higher Vrel than the wild-type enzyme. However, the
decrease of the reaction rate with respect to GlcNAc (8)
promoted by the axial position of the NHAc group of
15 and the galacto conﬁguration of C-4 of 16 was simi-
lar for the wild-type and the mutant enzymes and
therefore, it is unclear if the inﬂuence of these changes is
diﬀerent in both enzymes.
Discussion
We have cloned and expressed a C-terminal truncated
mutant of the a 1,6 FucT from Rhizobium sp. From the
data obtained, we can make some comments about the
location of the active site of the enzyme. Although it is
generally accepted that in mammalian glycosyl-
transferases the active center is located in the C-terminal
portion of the enzyme,13 some data point out that in
other organisms this situation could be diﬀerent. For
example, recently it has been reported that a N-terminal
truncated a 1,2 FucT from Helicobacter pylori showed
no activity.14 Therefore, the main objective of the pre-
sent work was to test if by deleting the C-terminal frag-
ment containing the predicted transmembrane-like
region, an improvement of the expression and stability
in solution of the a 1,6 FucT could be achieved without
losing the transferase activity. This hypothesis has been
conﬁrmed by the results obtained. The mutant protein
showed transferase activity and it was expressed exclu-
sively in soluble form. The inﬂuence of the highly
hydrophobic segment on the low stability in solution of
the wild-type enzyme was also conﬁrmed since the
mutant did not lose activity after 5 days at 4 C and no
protein precipitation was observed (Fig. 3).
Oriol et al.,15 using hydrophobic cluster analysis (HCA)
deﬁned three peptide motifs, which are conserved in a
1,6-fucosyltransferases found in vertebrates, inverte-
brates and bacteria. The a-6-motifs I and II are shared
by eukaryotic and prokaryotic a 1,2-fucosyltransferases,
whereas the a-6-motif III is speciﬁc of the a 1,6
family.15,16 The a-6-motif III of the Rhizobium sp. a 1,6
FucT is found in the fragment that was deleted in our
mutant enzyme (Fig. 1). Therefore, our results show
that this motif is not essential for the activity of the
enzyme, although it remains unclear whether it can play
any role in the donor and/or acceptor substrates bind-
ing. On the other hand, it has been recently demon-
strated that the Arg-365 of the human a 1,6 FucT is
essential for the enzyme activity, participating in both
the catalysis and the binding of the donor substrate.17
This residue belongs to the a-6-motif I and in the
sequence of the Rhizobium enzyme corresponds to the
Arg-176.
The C-terminal truncation of the a 1,6 FucT did not
change drastically the speciﬁcity towards the acceptor
substrate. However, the branched thio-trisaccharide
Galb1!4[S-Fuca(1!3)]GlcNAcb-OBn (7), which was
not substrate for the wild-type enzyme possibly due to
steric hindrance, was accepted by the mutant transferase
(Table 2) although at a low rate. This result suggests
that the acceptor substrate binding site could be wider
or more ﬂexible in the truncated a 1,6 FucT than in the
wild-type enzyme. This higher ﬂexibility could also
account for the higher reaction rates showed by the
truncated enzyme with chitotetraose (3). Higher versa-
tility in the binding modes of the truncated enzyme
could also be the origin of certain levels of non-produc-
tive binding as suggest the apparently lower values ofKM
and Vmax for the mutant compared with the wild-type
enzyme towards GDP-Fuc (Table 1).
On the other hand, it is noteworthy that both the wild-
type and the truncated a 1,6 FucT are able to fucosylate
the a and the b benzyl glycosides of GlcNAc with
Table 2. Comparison of the acceptor speciﬁcity of wild-type and
truncated a 1,6-FucT using GDP-b-l-fucose as donor
Acceptor Vrel (%)
a
W-T Mutant
Chitin oligomers
[GlcNAcb1!4]2 (1) 100 100
[GlcNAcb1!4]3 (2) 106 114
[GlcNAcb1!4]4 (3) 126 170
Di- and trisaccharides
Galb(1!4)GlcNAc (4) 56b 56
Fuca(1!3)GlcNAcb-OPr (5) 31b 27
S-Fuca(1!3)GlcNAcb-OBn (6) 36b 32
Galb(1!4)[S-Fuca(1!3)]GlcNAcb-OBn (7) 0b 11
Monosaccharides
GlcNAc (8) 18b 36
GlcNAcb-OMe (9) 39b 42
GlcNAcb-OBn (10) 51b 56
GlcNAca-OBn (11) 53b 51
GlcNAcb-OSiMe (12) 0b 0
GlcNH2 (13) 18
b 25
Glc (14) 9b 12
ManNAc (15) 12b 23
GalNAc (16) 9b 21
aRelative velocities using 50 mM GDP-Fuc, 100 mM acceptor and 3.3
mU of enzyme. The values are referred to the reaction rate with chit-
obiose.
bData taken from ref 5.
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similar reaction rates (10 and 11, Table 2). The lack of
selectivity for the anomeric conﬁguration of the accep-
tor seems to be a general feature of bacterial glycosyl-
transferases, since a similar behaviour has been
described for the a 2,3-sialyltransferase4c and the b 1,3-
N-acetylglucosaminyltransferase,4d both from Neisseria
meningitidis.
Conclusion
In conclusion, we have shown that the deletion of a C-
terminal fragment of the a 1,6-FucT from Rhizobium sp.
led to a mutant enzyme retaining the catalytic and spe-
ciﬁcity features. However, such truncation allowed us to
obtain higher yields of soluble transferase per unit of
biomass and with improved stability in solution, which
represent a signiﬁcant advantage. Work is in progress
for a more detailed kinetic characterization of both
wild-type and mutant fucosyltransferases.
Experimental
Materials
Rhizobium sp. NG234R strain was provided from the
Microbiology Laboratory, ETSIA, Universidad Poli-
te´cnica de Madrid (Spain). E. coli competent cells XL1-
Blue MRF’ were purchased from Stratagene Co. (San
Diego, CA, USA). pKK223-3 vector was obtained from
Pharmacia Biotech. Inc.(Piscataway, NJ, USA). Taq
DNA polymerase was purchased from Ecogen (Spain).
T4 DNA ligase was obtained from MBI Fermentas AB
(Lithuania). Restriction enzymes Eco RI and Hind III
were purchased from Boehringer Manheim (Germany).
IPTG was purchased from Applichem GmBH (Ger-
many). Pyruvate kinase type II from rabbit muscle, l-
lactic dehydrogenase type II from rabbit muscle, phos-
phoenol pyruvic acid (PEP), b-NADH, GlcNAc,
GlcNH2, Glc, ManNAc and GalNAc were obtained
from Sigma St. Louis, MO). N,N0-Diacetylchitobiose,
N,N0,N00-triacetylchitobiose, N,N0,N00,N000-tetraacetyl-
chitobiose, and N-acetyllactosamine were obtained from
Toronto Research Chemicals (Ontario, Canada). GDP-
Fuc was purchased from Oxford GlycoSciences (UK).
The oligosaccharides Fuca(1!3)GlcNAcb-OPr, S-
Fuca(1!3)GlcNAcb-OBn, Galb(1!4)[S-Fuca(1!3)]
GlcNAcb-OBn, GlcNAcb-OSiMe, GlcNAcb-OMe,
GlcNAca-OBn and GlcNAcb-OBn were previously
synthesized in our laboratory. 18All other chemicals
were purchased from commercial sources as reagent
grade.
C-Terminal truncation
C-terminal truncation of the a 1,6-FucT from Rhizo-
bium sp. was performed by PCR. The rightward primer
was designed to complement 15 bp from nucleotide 757
to 771 of the coding strain, the stop codon TGA and the
recognition sequence for Hind III were also included.
DNA of Rhizobium sp. was used as template. The
oligonucleotides 50-GCCGCGAATTCATGTACAAT-
CGATAT-30 and 50-CGCGCAAGCTTTCAATCTG-
CGCTGTGTAA-30 were used as leftward and
rightward primers respectively. PCR ampliﬁcation was
performed in a 100 mL reaction mixture containing 3 mL
of DNA template, 70.5 mL of water, 10 mL of 10buﬀer
(100 mM Tris–HCL, 500 mM KCl, pH=8.0), 2 mM
MgCl2, 200 mM of dNTPs, 1 mM of primers and 2.5 U
of Taq DNA polymerase. The reaction was subjected to
30 cycles of ampliﬁcations. The cycle conditions were
set as follows: denaturation at 94 C for 1 min, anneal-
ing at 55 C for 1.5 min, and elongation at 72 C for
1 min.
Construction of the pK1,6FucTDS expression vector
The 771 bp band obtained from the PCR was puriﬁed
with the Wizard PCR Preps DNA Puriﬁcation System
(Promega; Madison, WI, USA). The insert and the
pKK223-3 plasmid were digested with Eco RI (100 U)
and Hind III (100 U) in 100 mL reaction mixtures fol-
lowing standard protocols.19 After puriﬁcation, the
insert was ligated with the vector using T4 DNA ligase.
The pK1,6FucTDS expression vector constructed in this
way was used to transform E. coli XL1-Blue MRF’
competent cells that were then plated on LB agar plates
containing 250 mg.mL1 ampicillin. Ten colonies were
randomly selected and grown up for screening of posi-
tive clones. The plasmid was puriﬁed by the Ultra Clean
Mini Plasmid Preparation kit (Mo Bio Laboratories,
Inc.; Solana Beach, CA, USA) and characterized by
restriction analysis. One positive clone was selected and
used for protein expression.
Expression of the truncated  1,6-FucT
The selected clone was grown up on 100 mL of LB
medium containing 250 mg mL1 ampicillin at 37 C
with shaking. When the cell growth reached an optical
density at 600 nm (O.D.600) of 0.5, the temperature was
switched to 30 C and the culture was induced with 1
mM IPTG. At diﬀerent times (3, 5 and 24 h) after
induction samples were taken and analyzed by SDS-
PAGE20 using 12,5% polyacrylamide in the separating
gels.
Activity and stability assays
The culture broth was centrifuged (3000g, 30 min, 4 C),
and the cell pellets were treated with lysozyme or with
Bacterial Protein Extraction Reagent (B-PERTM,
Pierce; Rockford, IL, USA) to separate the soluble
proteins from the inclusion bodies. The a1,6-FucT
activity was assayed with a coupled enzymatic system,
where the decrease of NADH absorbance at 340 nm is
directly proportional to the release of GDP during the
fucosyltransferase-catalyzed reaction.9 The activity was
measured at 25 C for 15 min in a ﬁnal volume of 1 mL,
containing 12 mM Hepes (pH 7.7), 13 mM MnCl2, 50
mM ClK, 6.5 mM MgCl2, 0.7 mM PEP, 0.2 mM
NADH, 7.6 U pyruvate kinase, 18 U lactate dehy-
drogenase, 100 mM of chitobiose and 52 mM of GDP-
Fucose. Acceptor was omitted for the blank. The assay
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was initiated upon addition of 25 mL (3.3 mU) of the
truncated a1,6-FucT preparation and the decrease in
the absorbance at 340 nm was monitored. In order to
make sure that the activity detected was due to the pre-
sence of the truncated enzyme, a control using E. coli
extract harboring the plasmid pKK223-3 without insert
was performed. Protein concentration was determined
using the Bio-Rad (Hercules, CA, USA) Protein Assay
kit, based on the Bradford dye-binding procedure.21
One unit of enzyme activity is deﬁned as the amount
that catalyzes the transfer of 1 mmol of fucose from
GDP-Fuc to chitobiose per min.
For the stability study the enzymes were kept at 4 C in
Tris–HCl buﬀer 50 mM, pH 8.0, containing 10 mM
EDTA.
Kinetics analysis and acceptor speciﬁcity study
Kinetic parameters were calculated for the donor sub-
strate GDP-Fuc. The analysis conditions were essen-
tially the same as described above except for the
concentration of GDP-Fuc that was varied from 7 to
240 mM. Apparent kinetic parameters were obtained
from the [s]/n against [s] plot. For the study of the
acceptor speciﬁcity chitobiose was substituted by
compounds described in Table 2.
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